Two fighters from the UFC’s back-to-back events during International Fight Week failed their drug tests.
Kevin Casey at UFC 175 and Robert Drysdale at The Ultimate Fighter 19 Finale were tested following their respective bouts, and each failed. Both on Thursday had their temporary suspensions officially confirmed by the Nevada Athletic Commission, pending a full hearing before the commission and final action at a future date.
NAC Chair Francisco Aguilar confirmed to MMAWeekly.com that Casey tested positive for Drostanolone, while Drysdale’s result revealed an elevated Testosterone-to-Epitestosterone ratio.
Casey initially recorded a one-minute TKO victory over Bubba Bush at UFC 175 on July 5, but that result will be turned to a no contest as long as the drug test results hold true. The bout was Casey’s second in the Octagon, having lost on the The Ultimate Fighter 17 Finale to Josh Samman.
Drostanolone is an anabolic steroid and is on the World Anti-Doping Association list of prohibited substances.
Drysdale’s T/E ratio was 12-to-1, according to Aguilar, which is well above the state’s limit of 6-to-1. An elevated T/E ratio can be indicative of exogenous testosterone use.
This is the second time that Drysdale has tested for an elevated T/E ratio. When he attempted to gain a license to fight Cody Donovan at UFC 167, Drysdale’s out-of-competition drug test showed a 19.4-to-1 ratio, thus he was refused a license.
Drysdale submitted Keith Berish in the opening round of their fight, but like Casey, the result of the bout is likely to be changed to a no contest, pending the outcome of his NAC hearing.
UFC 175 took place on Saturday, July 5, at the Mandalay Bay Events Center in Las Vegas, while the TUF 19 Finale took place the following night at the same venue.